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Breast Cancer and the Politics of Abortion
in the United States
PATRICIA JASEN*
Epidemiology, like any branch of medical science, functions within a social and histor-
ical context. That context influences what questions are asked, how they are investigated,
and how their conclusions are interpreted, both by researchers and by the public. The
international debate over whether abortion increases breast cancer risk, which has been
the subject of many studies and much heated controversy in recent decades, became so
intensely politicized in the United States that it serves as a particularly stark illustration
of how elusive the quest for scientific certainty can be. Although a growing interest
in reproductive factors and breast cancer risk developed after the Second World War,
it was not until the early 1980s, after induced abortion had been legalized in many
countries, that studies began to focus on this specific factor. In the US these were the
years following Roe v Wade, when anti-abortionists mounted their counterattack and pro-
choice forces were on the defensive. As a result, epidemiologists found themselves at the
centre of a debate which had come to symbolize a deepening divide in American culture.
This paper traces the history of the scientific investigation of the alleged abortion-breast
cancer link, against the backdropof what was increasingly termed an ‘‘epidemic’’ of breast
cancer in the US. That history, in turn, is closely intertwined with the anti-abortion move-
ment’s efforts, following the violence of the early 1990s, to regain respectability through
changing its tactics and rhetoric, which included the adoption of the ‘‘ABC link’’ as part of
its new ‘‘women-centred’’ strategy.
Background
OfallthecancerswhichafflicttheWesternworld,breastcancerhasbeenthefocusofthe
longest historical controversy over what its causes may be and why some women are more
vulnerable to the disease than others.
1 Common explanations have ranged from blows
to the breast to the effect of unhappy emotions, but have also focused on the influence of
events in women’s reproductive lives.
2 Opinion was long divided over whether childless
women were at greater or lesser risk, and the same controversy surroundedthe significance
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423of breast-feeding.
3 More definitive answers awaited the improvement of data collection
and analysis as the field of epidemiology developed in the twentieth century. The first
study to include both a large group of breast cancer patients and a control group of healthy
women was conducted in Britain in the 1920s by Janet Lane-Claypon, and she found
consistent differences between the two groups in relation to age at marriage, fertility, and
lactation.
4Shealsopositedthatlifetimeexposuretooestrogenwasasignificantfactor,and,
by the 1940s, endocrinologists were paying closer attention to the role of hormones in
breast cancer.
5
The study of reproductive factors in relation to breast cancer continued after the Second
World War, as researchers expanded the number of variables taken into consideration,
including the use of hormone replacement therapy and, by the mid-1960s, the use of oral
contraceptives. Even though attention was not focused on abortion until the early 1980s, it
also began to receive brief mention as a possible risk factor. The earliest study cited in the
epidemiological literature dates back to the 1950s, when researchers in the Department
of Public Health at Tohoku University Medical School published a wide-ranging study of
all common cancers in Japan. They found slightly higher rates of spontaneous abortion
and significantly higher rates of induced abortion among cancer patients, but were hesitant
to draw any firm conclusions because of methodological weaknesses in their study.
Although their cautionary comments were usually ignored by later researchers when
citing their report, the Tohoku team were explicit about their concern that the women
in the control group, who were not facing a life-threatening disease, were less likely
to report a past history of induced abortion, thus making it impossible to draw any
conclusions about a cancer link.
6 In later years, this phenomenon would be referred to
as ‘‘recall bias’’.
Intensive researchinto the role abortion might play in breastcancer risk would not begin
for another quarter century but, during the intervening years, the legal status of the
procedure changed in many countries, making it possible for the subject to be discussed
more openly, and for more accurate statistical records to be kept. By far the greatest
controversy surrounding this area of research would develop in the US, where the debate
over abortion was passionate and deeply divisive. Prior to 1973, abortion was illegal in
thirty US states, with the exception of cases where the life of the mother was in danger,
while in at least a dozen others abortion was permitted only in cases of rape or incest, or if
the fetus suffered severe abnormalities.
7 Abortion law was thus very inconsistent from one
3For differing views among nineteenth-century
authorities, see Walter H Walshe, The nature and
treatmentofcancer,London,TaylorandWalton,1846,
p. 154; W Roger Williams, A monograph on diseases
of the breast, their pathology and treatment, with
special reference to cancer, London, John Bale, 1894,
pp. 287–8; William Rodman, Diseases of the breast
with special reference to cancer, Philadelphia,
Blakiston, 1908, pp. 181–2; Willard Parker, Cancer:
a study of three hundred and ninety-seven cases of
cancer of the female breast, New York, Putnam,
1885, p. 22.
4De Moulin, op. cit., note 1 above, pp. 89–90.
5See Ira T Nathanson, ‘The relationship of
hormones to diseases of the breast’, in G H Twombly
and G T Pack (eds), Endocrinology of neoplastic
diseases: a symposium by eighteen authors,
New York, Oxford University Press, 1947,
pp. 138–78.
6M Segi, I Fukushima, S Fujisaku, M Kurihara,
S Saito, K Asano, and M Kamoi, ‘An epidemiological
study on cancer in Japan’, GANN: Japanese Journal
of Cancer Research, 1957, 48 (Supplement), p. 42.
7JamesRisenandJudyLThomas,Wrathofangels:
the American abortion war, New York, Basic Books,
1998, p. 36.
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Patricia Jasenjurisdiction to another; in some states, even providing information on how to obtain an
abortion elsewhere could lead to arrest.
8 Challenges to abortion laws across the US
eventually led to the sweeping decision by the Supreme Court on 22 January 1973.
While Roe v Wade did not recognize a woman’s ‘‘absolute right’’ to an abortion under
the Constitution, it allowed (but did not require) states to regulate abortion only after the
fetus was viable (i.e. inthe third, orinsomecasesthe second, trimester).By1980, over one
and half million abortions were being reported each year. The majority of them were
performed in freestanding clinics, which mushroomed even in the weeks that followed
Roe v Wade.
9
The ruling brought an immediate reaction from opponents of abortion. As James Risen
and Judy Thomas explain, even some pro-choice advocates, such as SC Justice Ruth Bader
Ginsburg, believed that Roe v Wade ‘‘went too far, too fast, taking a giant leap the country
was not prepared to make’’.
10 The battle had only begun, and would now become closely
tied to a major transformation in American religious and political life during the last
quarter of the century, for the anti-abortion movement grew very much in tandem with
the rise of evangelical Christianity in the United States. Before abortion was legalized, the
Roman Catholic hierarchy had been the force behind most of the lobbying but, follow-
ing Roe v Wade, they were joined by increasingly militant, and increasingly numerous,
Protestant fundamentalists dedicated to the anti-abortion cause. Although the drift towards
direct action strategies had its origins in the tactics of Catholic leftists of the 1960s,
Christian fundamentalism would soon transform ‘‘civil disobedience into a conservative
tool’’ and become associated with right-wing politics and opinion.
11 Of even greater
significance, however, was the grassroots, anti-establishment nature of that conservatism.
Anti-abortionists discovered that conservatives in high places could not necessarily be
countedupon,andtheirleaders,liketheirpreachers,weredrawnfromtheranksofordinary
Americans, so that the increasingly apocalyptic rhetoric of the movement was infused with
astronglypopulistimpulse.Christianrevivalism,fusedwith‘‘pro-life’’activism,strovefor
the awakening of all of America to ‘‘the horrors, the evil, and the truth of abortion’’.
12
Abortion-Breast Cancer Research to 1994
When research into a possible link between abortion and breast cancer began in earnest
in the early 1980s, there was no hint that, within a few short years, epidemiologists would
be thrust into the wider debate over abortion in the US. The first published studies
represented a growing interest in an aspect of women’s reproductive lives which could
now be reported and discussed more openly, and they were part of an expanding inter-
national dialogue in which American researchers took a very active part. This section of
the paper will examine the tentative and conflicting conclusions reached during the 1980s
and early 1990s, but will first consider how some earlier studies were used to provide a
8Cynthia Gorney, Articles of faith: a frontline
history of the abortion wars, New York, Simon and
Schuster, 1998, pp. 151–2.
9Risen and Thomas, op. cit., note 7 above,
pp. 15–16, 36, 106.
10Ibid., pp. 37–9.
11Ibid., pp. 19, 39–40.
12Carol Mason, Killing for life: the apocalyptic
narrative of pro-life politics, Ithaca, Cornell
University Press, 2002, p. 2; see also Kerry N Jacoby,
Souls, bodies, spirits: the drive to abolish abortion
since 1973, Westport, CT, Praeger, 1998, p. 154.
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Breast Cancer and the Politics of Abortion in the United Statesfoundation for later work. It should be noted that the common means of conveying results
throughout this literature was to indicate the degree of ‘‘relative risk’’ (RR) posed by
abortion. For example, a relative risk of 1.5 suggests that women who have had abortions
have a 50 per cent higher risk than other women, when all other factors have been
controlled. The meaningfulness of such figures depends on many elements, including
the ability of researchers to separate abortion from confounds and from other risk factors,
the appropriateness of the control group, the numbers of women in the study, the accuracy
of reporting abortions, and the extent to which low levels of relative risk (below RR¼2.0)
can be considered significant.
In epidemiological literature, when interest in a potential risk factor is developing, its
possible significance sometimes gains credibility from early, tentative evidence which
seems to provide some shaky support for the hypothesis being tested. In this manner,
a historical process begins, common in scientific research, whereby these early studies are
cited again and again, without due attention to the context in which they were conducted,
the validity of their results, or even the precise nature of their conclusions. This was very
much the case with the abortion-breast cancer debate. The early Japanese study was often
cited in support of a link, and much weight was given to a series of international studies
on breast cancer epidemiology conducted during the late 1960s by Brian MacMahon in
collaboration with researchers in both eastern Europe and Asia.
13 They investigated a wide
range of reproductive factors, but abortion did receive brief mention in each study. The
findings were inconsistent, and in one study fewer abortions than expected or predicted
were reported by women who had become cancer patients.
14 But when MacMahon and his
co-authors summarized these results in a much cited article published by the American
Journal of the National Cancer Institute in 1973, they inaccurately concluded that, even
thoughabortionwas not consistentlylinked to cancer, ‘‘where a relationship was observed,
abortion was associated with increased, not decreased, risk’’.
15
Proceeding from an understanding (derived from MacMahon, et al.) that abortion was
an already established risk factor for human breast cancer, Jose and Irma Russo of the
Michigan Cancer Foundation in Detroit set out in 1978 to discover the mechanism behind
this link. They introduced carcinogens into rats in order to investigate the influence of
pregnancy interruption, compared with full pregnancy and lactation, on tumour develop-
ment. Their study supported the theory that structural changes in breast tissue are respon-
sible for the lasting, protective effect of full-term pregnancy. They observed that abortion
left the rats highly susceptible to developing cancer, but that the aborted rats ‘‘were at the
same riskas virginanimals treated withthe carcinogen’’
16(italicsmine).Overthe next two
decades, however, their findings would be cited repeatedly as evidence that pregnancy
13V G Valoras, B MacMahon, D Trichopoulos and
A Polychronopoulou, ‘Lactation and reproductive
histories of breast cancer patients in Greater Athens,
1965–67’, Int. J. Cancer, 1969, 4: 350–63; S Yuasa
and B MacMahon, ‘Lactation and reproductive
histories of breast cancer patients in Tokyo, Japan’,
Bull. WHO, 1970, 42: 195–204; T M Lim, K P Chen,
and B MacMahon, ‘Epidemiologic characteristics
of cancer of the breast in Taiwan’, Cancer, 1971,
27: 1497–1504; B Ravnihar, B MacMahon and
J Lindtner, ‘Epidemiologic features of breast cancer
in Slovenia, 1965–67’, Eur. J. Cancer, 1971, 7:
295–306.
14Ravnihar, et al., op. cit., note 13 above, p. 301.
15B MacMahon, P Cole, and J Brown, ‘Etiology of
human breast cancer: a review’, J. Nat. Cancer Inst.,
1973, 50: 21–42, on p. 22.
16Jose Russo and Irma H Russo, ‘Susceptibility of
the mammary gland to carcinogenesis’, Am. J. Pathol.,
1980, 100: 497–512, on pp. 497–8.
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Patricia Jasenbegins a process of breast change which, when stopped by abortion, put female rats (and
thus humans) at greater risk of cancer than those who had never been pregnant.
17
The Russo study was published in 1980, and an international dialogue among research-
ers focused on the abortion-breast cancer question commenced in the British Journal of
Cancershortlythereafter.ItbeganwithastudyconductedbyMalcolmPike andcolleagues
at the University of Southern California. Their objective was to determine the influence of
both oral contraceptive use and early abortion, and, because oral contraceptives had only
beenincommonuseforjustoveradecade,theylookedatyoungerwomenonly—all163of
their cases had been diagnosed with breast cancer by the time they were 32 years of age.
18
Despite the methodological problems inherent inthis study, it gained long-lasting attention
because of its finding that women who had a first trimester induced or spontaneous
abortion before their first full-term pregnancy (often abbreviated as FFTP) had almost
a two and a half times greater risk of breast cancer (RR¼2.4) than women who had no
abortions. A later pregnancy reduced that level of risk, and abortions occurring after the
first trimester or after a FFTP carried no increased risk at all. Pike and his colleagues saw
their study as the first to report a ‘‘substantial increase in risk’’ specifically associated with
early abortion, and, in light of the growing abortion rate among young women in many
countries, they predicted their findings would be ‘‘of major importance’’.
19 The gauntlet
had been thrown down, and a British research team, already engaged in a long-term study
of reproductive factors in breast cancer patients treated at London and Oxford hospitals,
responded immediately to Pike’s ‘‘provocative and worrying results’’.
20 But in contrast
to Pike, they found no increase in risk associated with either oral contraceptive use or
abortion, and attributed this outcome to differences in methodologies and the ‘‘effect of
chance’’.
21
Conflicting results, and conflicting interpretations of results, would characterize the
abortion-breast cancer debate as it intensified throughout the decade. An international
array of cancer and epidemiological journals published studies which variously demon-
strated an increased risk, no evidence of risk, and even decreased risk of cancer following
abortion.
22 The interpretation of statistical findings was inconsistent as well, for a certain
17For an example of the continuing use of this
study, see Barry Yeoman, ‘The scientist who hated
abortion and did something about it’, Discover,
Feb. 2003, 24: 54–9, on p. 56.
18M C Pike, B E Henderson, J T Casagrande,
I Rosario, and G E Gray, ‘Oral contraceptive use and
early abortion as risk factors for breast cancer in young
women’, Br. J. Cancer, 1981, 43: 72–6, on p. 72.
19Ibid., pp. 75–6.
20M P Vessey, K McPherson, D Yeates, and
RDoll,‘Oralcontraceptiveuseandabortionbeforefirst
term pregnancy in relation to breast cancer risk’,
Br. J. Cancer, 1982, 45: 327–31, on p. 327.
21Ibid., pp. 330–1, on p. 330.
22M Ewertz and S W Duffy, ‘Risk of breast
cancer in relation to reproductive factors in Denmark’,
Br. J. Cancer, 1988, 58: 99–104, reported an increased
risk in nulliparous women; and H Howe, R T Senie,
H Bzduch, and P Herzfeld, ‘Early abortion and breast
cancer risk of women under age 40’, Int. J. Epidemiol.,
1989, 18: 300–4, reported an almost doubled risk
among women with induced abortions. Studies
which concluded that abortion did not result in a
statistically significant elevation in risk include
S P Helmrich, S Shapiro, L Rosenberg, D Kaufman,
D Slone, C Bain, O Miettinen, P D Stolley,
N Rosenshein, R C Knapp, T Leavitt Jr.,
DSchottenfeld,R.EngleJr.,andMLevy,‘Riskfactors
for breast cancer’, Am. J. Epidemiol., 1983, 117:
35–45; C La Vecchia, A Decarli, F Parazzini,
A Gentile, E Negri, G Cecchetti, and S Franceschi,
‘General epidemiology of breast cancer in northern
Italy’, Int. J. Epidemiol., 1987, 16: 347–55;
L Rosenberg, J R Palmer, D W Kaufman, B L Strom,
D Schottenfeld, and S Shapiro, ‘Breast cancer in
relation to the occurrence and time of induced and
spontaneous abortion’, Am. J. Epidemiol., 1988, 127:
981–9; B-M Lindefors Harris, G Eklund, O Meirik,
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Breast Cancer and the Politics of Abortion in the United Stateslevel of risk (usually in the range of RR¼1.2 to 1.5) was considered significant by some
and not by others—an issue still hotly debated in recent years, and part of the reason why
some of the same studies have been used as supporting evidence by opposing sides in the
debate.Somereportedthatmiscarriage wasassociatedwithalesserrisk(orevenanegative
risk) in comparison with induced abortion, while a much publicized study of Connecticut
women which included only spontaneous abortion found a 3.5 fold increase in cancer
incidence in women who miscarried before their first live birth.
23 Positive findings also
varied with respect to whether abortion posed a danger only if it occurred before the first
full-term pregnancy, or only among women who never carried a later pregnancy to term, in
which case there was often ambiguityas to whether or not women in the cancer group were
beingcomparedonlywithothernulliparouswomen.Notunexpectedly,researchersusually
drew upon preceding reports which they considered significant in relation to their own
findings, with some giving undue weight to studies involving very few women reporting
induced abortions or glossing over the inconsistencies which emerge from a closer exam-
ination of the data. The great majority of these studies were retrospective, case-control
studies, meaning that women were reporting their abortion histories after being diagnosed
for breast cancer (rather than before, as in prospective studies). During the 1980s, few
researchers openly considered the question of inaccurate reporting of past abortions by
participants.
The interest in younger women and cancer, initiated by Pike, persisted throughout this
period fora varietyof reasons. Records ofabortionwere more readily available for thisage
group, and researchers were very conscious of the fact that more and more young women
were choosing abortion. There was also some evidence, inconsistent and yet alarming, that
breast cancer rates among young women were on the rise; this trend was reported in the US
and Sweden, although not in the United Kingdom, and was apparently more pronounced
among young African-American women in the US. This last factor attracted the attention
of the epidemiologist Janet Daling at the Fred Hutchinson Cancer Research Center in
Seattle, Washington, who had already published widely on cancer epidemiology and
whose earlier research had examined the implications of abortion for future childbearing.
In 1987, she and her colleagues published a study of breast cancer incidence, in relation
to age and ethnicity, in the western portion of Washington state.
24 They observed a
22 per cent increase in breast cancer in women aged 25 to 44 over an eight-year period,
a change which could not, they felt, be accounted for by earlier detection or an overall
increase in breast cancer rates, as they reported (inaccurately, as they later discovered)
a declining incidence for women aged 45 to 54.
25 They found the greatest increase was
L E Rutqvist, and K Wiklund, ‘Risk of cancer of the
breast after legal abortion during first trimester:
a Swedish registry study’, Br. med. J., 9 Dec. 1989,
299: 1430–32; and F Parazzini, C La Vecchia, and
E Negri, ‘Spontaneous and induced abortions and
risk ofbreastcancer’, Int. J.Cancer, 1991,48: 816–20.
R S Paffenbarger Jr, J B Kampert, H-G Chang,
‘Characteristics that predict risk of breast cancer
before and after the menopause’, Am. J. Epidemiol.,
1980, 112: 258–68, found that risk was slightly
lowered.
23O C Hadjimichael, C A Boyle, and J W Meigs,
‘Abortion before first livebirth and risk of breast
cancer’, Br. J. Cancer, 1986, 53: 281–4.
24E White, J R Daling, T L Norsted, and J Chu,
‘Rising incidence of breast cancer among young
women in Washington state’, J. Nat. Cancer Inst.,
Aug. 1987, 79: 239–43, on p. 241.
25This misconception was later corrected;
see P Velentgas and J R Daling, ‘Risk factors for
breast cancer in younger women’, J. Nat. Cancer Inst.
Monographs, 1994, 16: 15–24, on p. 15.
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Patricia Jasenamong women in low-income urban areas (53 per cent) and among African-American
women (118 per cent), which contradicted the longstanding association between breast
cancer and white, middle-class prosperity. As a possible explanation for the overall trend,
they pointed to changes in reproductive patterns in the post-war period; as they noted,
among American women ‘‘born between 1950 and 1954, 48% were nulliparous at age
25 years, compared with 29% of women born between 1935 and 1939’’.
26 In addition,
they pointed out that many young women now delayed pregnancy through the use of oral
contraceptives and abortion, both of which were under suspicion as risk factors, and that
abortion rates were higher among black women than white women.
Daling and her colleagues were awaiting the results of a long-term study focused on
abortion and cancer in young women which would cause a considerable stir once it was
released. Meanwhile, the findings of other researchers contributed to the growing confu-
sion.ASwedish study reported that,although the increase inabortionrates had paralleled a
40 per cent increase in breast cancer among women aged 20 to 44, they found no associa-
tion between the two, while the studyby Holly Howe and her colleagues in New York state
reached the opposite conclusion.
27 As for the rising incidence of breast cancer among
young African-American women, an examination of this trend in the San Francisco Bay
area found that breast cancer had been increasing in the African-American population
throughout the post-war period, well before the legalization of abortion.
28 A team in the
eastern US concluded that there was some association between abortion and cancer in
African-American patients diagnosed after the age of fifty, but that spontaneous abortion
seemed to offer a small protective effect among the same group of women.
29
By the early 1990s, the debate over the possible link between abortion and breast cancer
was about to move beyond the pages of medical journals and into the public eye. This was
not, as yet, because of a growing concern among clinicians; a study of physicians’ percep-
tions of breast cancer risk conducted in southern California during 1991–2 revealed that
none of those interviewed mentioned abortion among the twenty-nine potential risk factors
listed.
30 Instead, public awareness of the controversy would come in the wake of Janet
Daling’s new study, outlined below. Like others, this study had its flaws, and would not
havereceivedmassmediacoverageandarousedtheinterestofanti-abortionpoliticiansifit
were not for two factors. Firstly, the alarming claim that there was an epidemic of breast
cancer in the United States, especially among younger women, had been widely reported
in the early 1990s and had become an intensely political issue. Secondly, the anti-abortion
campaign had reached a stage in its increasingly violent history when new strategies were
needed, and activists recognized that an association between abortion and breast cancer
could be very useful to their cause.
26White, et al., op. cit., note 24 above, p. 239.
27In 1989, two widely published studies reported
conflicting results concerning younger women. See
LindeforsHarris,etal.,op.cit.,note22above,p.1430;
Howe, et al., op. cit., note 22 above, p. 300.
28NKrieger,‘Socialclassandtheblack/whitecross
over in the age-specific incidence of breast cancer:
astudylinkingcensus-deriveddatatopopulation-based
registry’, Am. J. Epidemiol., 1990, 131: 804–14,
on pp. 804–5, 812.
29ALaing,FMDemenais,RWilliams,GKissling,
V Chen, and G Bonney, ‘Breast cancer risk factors in
African-American women: the Howard University
TumorRegistryexperience’,J.Nat.med.Assoc.,1993,
85: 931–9.
30J M McMullin, L R Chavez, F A Hubbell,
‘Knowledge, power and experience: variation in
physicians’ perceptions of breast cancer risk
factors’, Med. Anthropol., 1996, 16: 295–317,
on p. 306.
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During the same years as research into a possible abortion-breast cancer link was
intensifying so, too, was the militancy of the anti-abortion movement. Fundamentalist
Christianity and the New Right had become closely allied, but, after Republican Ronald
Reagan was elected president in 1980, there was disappointment and a sense of betrayal,
for the new administration did not seek to reverse Roe v Wade. In 1983 the Senate defeated
an amendment that would have returned the abortion issue to the state level, and there
continued to be about one and a half million abortions performed in the US each year.
31 As
the lobbying efforts of the non-violent majority in the movement seemed to have accom-
plishedlittle,supportersofdirectactionrosetoprominence,firstemployingtactics,suchas
sit-ins, inherited from the tradition of civil disobedience, but moving on by the mid-1980s
to clinic break-ins and bombings. Carol Mason has analysed the rise of an apocalyptic
narrative within the movement—the understanding that if abortion were not stopped, God
would cease to protect America.
32 The evangelical leaders Pat Robertson and Jerry Falwell
gave their support to the violent strategies of such groups as Operation Rescue, and at the
1988 Democratic convention in Atlanta hundreds of demonstrators were arrested. But
most politicians knew by that point that a majority of Americans had come to accept the
right of adults to seek early abortion, and the newly elected Republican leader, the elder
George Bush, would not commit his party—in his words—to a ‘‘litmus test’’ on the
abortion question.
33 The belief that they had once again been abandoned by the conser-
vativeestablishmentencouragedevenmoredesperatemeasuresonthepartofanti-abortion
activists, but the 1993 murder of the physician David Gunn irreparably harmed the move-
ment. In 1994, President Clinton signed the Freedom of Access to Clinic Entrances Act
(known as FACE), and the Supreme Court ruled that lower courts could establish ‘‘protest-
free buffer zones’’ around abortion clinics. Arsons, bombings, and murders of clinic
workerscontinuedduringthatyear,leadingtothecollapseofviolentanti-abortionactivism
in the US.
34 Organizations such as National Right to Life reasserted their leadership in the
movementandpursuedmoretargetedstrategies,includingoppositiontolate-termabortion
(termed partial-birth abortion) and to FDA approval of the abortion drug RU-486.
35 They
also began to use the alleged abortion-breast cancer link to discourage women from
abortion and to demand new legislation.
The widespread belief that a breast cancer epidemic was under way in the US seemed
to substantiate the movement’s theory that the ‘‘abortion generation’’—younger women
who had become sexually active in the twenty years since Roe v Wade—were now reaping
the consequences of their freedom to terminate pregnancies at will.
36 The notion of an
epidemicrequirescloserexamination,foritaroselargelyfromaninaccurate understanding
of breast cancer history. It was true that there had been a moderate but steady increase in
31Risen and Thomas, op. cit., note 7 above,
pp. 130, 241.
32Mason, op. cit, note 12 above, p. 4.
33Risen and Thomas, op. cit., note 7 above, p. 276.
34David Garrow, Liberty and sexuality: the
right to privacy and the making of Roe v Wade,
Berkeley, University of California Press, 1998,
pp. 705–14.
35Risen and Thomas, op. cit., note 7 above,
pp. 373–6.
36For example, the president of Abortion Industry
Monitor wrote that ‘‘Abortion...can explain many
features of an otherwise mystifying worldwide
breast cancer epidemic’’. See Scott W Somerville,
‘Does abortion increase the risk of breast cancer?’,
J. Med. Assoc. Georgia, 1994, 83: 209–10, p. 210.
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Patricia Jasenbreast cancer rates since the 1940s, but the more recent and alarming rise in diagnoses was
in good part due to early detection through mammography. This conclusion was supported
by the fact that the increase was seen mainly in the early stages of the disease, that the
greater increase occurred not in young women but in those over fifty (the age group most
likelyto be effectivelyscreened), and that rates had levelled offby the late 1990s, as would
be expected if the increase were due to early detection.
37 Paula Lantz and Karen Booth
have examined the role played by the media in raising fears of an epidemic in the US—
how the disease was portrayed as being out of control, and how the discussion of repro-
ductive factors, such as birth control and delayed childbearing, underscored the frequent
suggestion that it was young, white, ‘‘liberated’’ women who were in the greatest danger.
Lantz and Booth found, for example, that 85 per cent of the case studies and anecdotes
found in popular magazines described women who were under fifty, whereas only 20 per
cent of those diagnosed were in that age group. The number of such articles increased
dramatically during the 1990s, and, after 1993, induced abortion was added to the list of
risk factors mentioned. Lantz and Booth propose that the portrayal of women as victims of
their own behaviour may be seen in the context of a backlash against the power and
autonomy that women had achieved through controlling their fertility, and it was certainly
the case that anti-abortionist literature increasingly linked the fight against breast cancer
with the struggle to preserve conservative ‘‘family values’’.
38
The most vocal proponent of an abortion-breast cancer link in the early 1990s was Joel
Brind, a professor of biochemistry at Baruch College in New York City. His area of
academic research had been the study of blood levels of steroids in relation to disease.
In 1985, he experienced (in his words) ‘‘a major course correction’’ when he converted
from Judaism to Christianity, and thereafter he sought to reconcile his professional life
with his newfound religious conviction. Brind became involved with National Right to
Life, and, wishing to devote his scientific expertise to the cause, he began by providing
information on the steroid abortion drug, RU-486. Another turning point came when he
read an article in Science News which discussed the most recent research of Malcolm Pike
(who had drawn attention to abortion and cancer risk in young women back in 1981). This
article focused on the apparent protection that pregnancy offered against breast cancer, but
omitted to say that the pregnancy had to be full-term or to mention Pike’s earlier findings
regarding abortion. Now convinced that the link was real, that knowledge of it was ‘‘being
actively suppressed’’, and that the Lord wished him to ‘‘bring this life-saving knowledge
into public awareness’’, Brind protested, but Science News failed to publish his letter.
Further efforts did not bring the recognition he desired, and his belief in a conspiracy of
37P M Lantz and K M Booth, ‘The social
construction of the breast cancer epidemic’, Soc. Sci.
Med., 1998, 46: 907–18, on pp. 907–8; S E King and
D Schottenfeld, ‘The ‘‘epidemic’’ of breast cancer in
the US–determining the factors’, Oncology 1996, 10:
453–62; G Gigerenzer, Reckoning with risk: learning
to live with uncertainty, London, Penguin, 2002,
pp. 77–80. The National Cancer Institute confirmed
that ‘‘No increases in breast cancer incidence were
apparent in either black or white women less than
50 years old’’; H L Howe, P A Wingo, M J Thun,
LAGRies,HMRosenberg,EGFeigal,BKEdwards,
‘Annual report to the nation on the status of cancer
(1973 through 1998), featuring cancers with recent
increasing trends’, J. Nat. Cancer Inst., 6 June 2001,
93: 824–42, on p. 827.
38Lantz and Booth, op. cit., note 37 above,
pp. 910–17; see also D Lupton, ‘Femininity,
responsibility, and the technological imperative:
discourses on breast cancer in the Australian press’,
Int. J. Health Services, 1994, 24: 73–89, on
pp. 82–3.
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Breast Cancer and the Politics of Abortion in the United Statessilence—and his vision of his own messianic role—seem to have been born at this time.
39
He began publishing regularly on this issue in the anti-abortion press, confident that his
efforts would ‘‘spare many women the agony of breast cancer’’.
40
It was in this atmosphere of heightened tension and growing militancy that an article
published in the Journal of the National Cancer Institute, along with its accompanying
editorial, came to occupy centre stage in this debate. In the autumn of 1994, Janet Daling
and her colleagues reported the findings of their much anticipated study of breast cancer
in the generation of women ‘‘born recently enough to have had some or most of their
reproductive years after the legalization of induced abortion’’.
41 As was the case in
most such studies, their methodology involved in-person interviews with cases and con-
trols in order to collect detailed information on the women’s reproductive histories. After
attempting to take other risk factors into account, they found that, among women who had
been pregnant atleast once, those who had hadan induced (but not a spontaneous)abortion
had a 50 per cent higher risk of developing breast cancer before the age of 45 (RR¼1.5)
than those who did not, and that the highest risk was associated with abortion in the last
monthofthefirsttrimester(RR¼1.9).Contrarytosomepreviousstudies,includingthatof
Pike and his colleagues, they reported no difference in risk associated with the number of
abortions or in women with completed pregnancies. Much would be made by Brind and
others of the findings which concerned women who had aborted before the age of 18. For
this group, the relative risk was 9.0 if the abortion took place between 9 and 24 weeks of
pregnancy, and all twelve of the women with a family history of breast cancer who had
aborted before the age of 18 had later been diagnosed with breast cancer. But these
categories represented less than 3 per cent of the total of 845 cancer cases, and the
interpretation of such figures would also be complicated by the fact that cancer patients
who had never had a completed pregnancy were being compared with a control group of
parouswomen.
42Dalingherselfwarnedagainstreaching‘‘afirmconclusionatthetime’’.
43
In fact, Daling and her team published a study two years later which found that abortion
was associated with a relative risk of only 1.2, that ‘‘there was no excess risk of breast
cancerassociatedwithinducedabortionamongparouswomen’’,andthattherewasnosub-
group ‘‘in whom the relative risk associated with induced abortion is unusually high’’.
44
That report would go largely unnoticed.
39Joel Brind, ‘Reading the data: defining a link
between abortion and breast cancer’, Physician
Magazine, July/August 2000, pp. 1–7, on pp. 2–4. This
journalnolongerhas a printedversion,andcanonlybe
found online; the address is: http://www.family.org/
physmag/pastissues/A0012416.cfm (accessed 16 Oct.
2003). It was also circulated in pamphlet form by an
organization called Focus on the Family. On the
developing controversy involving Pike and others, see
Troy Parkins, ‘Does abortion increase breast cancer
risk?’, J. Nat. Cancer Inst., 15 Dec.1993, 85:
1987–8. Pike’s research dealt with whether women
could gain the protective effects of pregnancy through
the use of hormones; for a critique, see Susan Rennie,
‘Imagine the profits if half the healthy population
were put on yet another drug’, Ms., May/June 1993,
3: 42–6.
40Joel Brind’s web page, Department of Natural
Sciences Faculty website, Baruch College, City
University of New York, http://www.baruch.cuny.edu/
wsas/departments/natural science/faculty/brind.html
(accessed 2 Nov. 2003).
41J R Daling, K E Malone,L F Voigt, E White, and
N S Weiss, ‘Risk of breast cancer among young
women: relationship to induced abortion’, J. Nat.
Cancer Inst., 2 Nov. 1994, 86: 1584–92, on p. 1584.
42Ibid., pp. 1585–92.
43Daling, et al., op. cit., note 41 above, p. 1592.
44J R Daling, L A Brinton, L F Voigt, N S Weiss,
R J Coates, K E Malone, J B Schoenberg, and
M Gammon, ‘Risk of breast cancer among white
womenfollowinginducedabortion’,Am.J.Epidemiol.,
15 Aug. 1996, 144: 373–80, on pp. 373, 375.
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Patricia JasenThepositivecorrelationsDalingreportedin1994wouldgiveproponentsoftheabortion-
breast cancer link their strongest support to date, but, for Brind, the editorial that accom-
panied Daling’s report was almost as important as the study itself. Written by Lynn
Rosenberg of the Slone Epidemiology Unit at the Boston University School of Medicine,
the editorial reflected some of the wider debates under way in the discipline of epidemio-
logy in the 1990s, including the problem of recall bias inherent in retrospective studies,
and the questionable statistical significance of fairly low elevations in risk. It also drew
attention to some specific shortcomings and inconsistencies in Daling’s study, and to the
lack of a ‘‘convincing biologic mechanism’’ to explain why induced abortion posed a
danger while spontaneous abortion did not. Acknowledging the ‘‘intensity of emotion’’
surrounding the issue, Rosenberg ventured that, while Daling’s results provided leads for
the scientific community, it was questionable how they would be ‘‘informative to the
public’’ at that time. She concluded that ‘‘whatever future results show, the decision to
continue or terminate an unplanned pregnancy will still need to be based on a balanced
consideration of the entire range of relevant issues—personal ethical considerations, the
desire for a child, the ability to care for it, and the total health implications of continued
pregnancy versus induced abortion’’.
45 For Brind, Rosenberg’s efforts to defuse the issue
gave credence to his repeated accusations that the National Cancer Institute was deter-
mined to cover up or discredit research pointing to an abortion-breast cancer link.
The publication of Daling’s report and Rosenberg’s response unleashed a reaction that
put pro-choice advocates on the defensive. Time magazine reported that, months before
the results were officially released, anti-abortionists ‘‘laid plans to trumpet the seven-year
study’s findings’’, while ‘‘in the opposition camp, pro-choice groups marshalled the
statistics they needed’’ to defend their position.
46 While the study was still in progress,
Daling was pursued for days by a Virginia lawyer employed by a right-to-life group trying
to recruit her as a spokesperson, and she recounted how she finally told him, ‘‘I don’t think
you care one bit about breast cancer and women’s health’’.
47 Once the report appeared,
newspapers, magazines, and television news shows publicized the highlights, many cau-
tiously, but some in a partisan fashion, either praising or criticizing the study. Daling
herself repeatedly told the media that politics and personal views should not be allowed
to cloud the issue, but it was inevitable that breast cancer would become a new weapon in
the abortion wars.
48 For example, Christ’s Bride Ministries rented space in rapid-transit
stations in the eastern US to advertise that ‘‘Women who choose abortion suffer more
and deadlier breast cancer!’’ (wording which Brind helped choose), and the federal order
to remove the posters in Philadelphia fuelled charges of a cover-up by Washington.
49
Meanwhile, anti-abortionists in Congress began a long campaign demanding hearings on
the abortion-breast cancer question, and more post-Reagan, New Right Republicans were
drawn to the issue. Doubting the effectiveness of sheer denial on the part of pro-choice
45Lynn Rosenberg, ‘Induced abortion and breast
cancer:morescientificdataareneeded’,J.Nat.Cancer
Inst., 2 Nov. 1994, 86: 1569–70.
46Christine Gorman, ‘Do abortions raise the
risk of breast cancer?’, Time, 7 Nov. 1994,
144: 61.
47Ibid.
48Ibid.; R Rubin, ‘Linking abortion and breast
cancer’, U.S. News and World Report, 7 Nov.
1994: 70.
49Yeoman, op. cit., note 17 above, p. 59.
The ads were removed in February 1996, but
returned two years later following a higher court
decision.
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attacking Daling’s study and dismissing its findings outright, ‘‘most pro-choice groups
have played right into Newt [Gingrich]’s hands’’.
50
Meanwhile, researchers produced new studies and engaged in a growing international
debate over methodological questions. Because retrospective studies still predominated,
the question of recall bias remained highly relevant, especially in light of a Swedish
study which suggested that it could result in a 50 per cent increase in reported risk.
51
One method of investigating the influence of recall bias was to examine differences in
responses among sub-groups of women involved in the studies. At the University of
Wisconsin Comprehensive Cancer Center, Madison, Polly Newcomb found a higher level
of risk for women who had abortions before 1973, suggesting a higher rate of under-
reporting among controls for the period when abortion was still illegal, while M A Rookus
of the Netherlands Cancer Institute found a higher association between abortion and
breastcancerinthemainlyRomanCatholicsouth-easternportionofthecountry,suggesting
that Catholic women in the control group were more likely to under-report.
52 Other
researchers addressed the question of why so many studies, including Daling’s, showed
no increased risk following spontaneous abortion. The standard answer was that failed
pregnancies were the result of hormonal deficiencies and did not affect breast tissue the
same way. But a Greek research team pointed out that this was true only in some cases, and
that a percentage of spontaneous abortions should have the same effect on cancer risk as
induced abortions. If the data did not reflect that fact, then ‘‘subtle information bias’’ must
be considered a possibility.
53 Given the conflicting nature of the data thus far and the
apparent problem of bias, the American Medical Association warned that legislative
initiatives already under way in some states by 1995 must be considered premature.
54
In Joel Brind’s view, such caution was mere cowardice or compliance with a pro-
abortion medical culture, and he heightened his efforts to reach a wider audience. He
wrote frequently about the problem of denial, as he saw it, in the anti-abortion press,
55
while continuing the fight against the legalization of RU-486, using the abortion-breast
50Bill Turque, ‘Aborted revolution?’, Newsweek,
12Dec.1994,124:38–40,onp.40;MichaelCastleman,
‘Abortion’s risk,’, Mother Jones (March/April 1995),
at http://www.motherjones.com/mother jones/
MA95/castleman.html (accessed 3 Nov. 2003).
Neo-conservative Newt Gingrich became
Speaker of the US House of Representatives in
January 1995.
51B M Lindefors-Harris, G Eklund, H O Adami,
and O Meirik, ‘Response bias in a case-control study:
analysis utilizing comparative data concerning legal
abortions from two independent Swedish studies’, Am.
J. Epidemiol., 1991, 134: 1003–8. See also E F Jones
and J D Forrest,‘Underreporting ofabortion in surveys
ofU.S.women:1976to1988’,Demography,1992,29:
113–26. Daling was involved in a later study which
found no evidence of recall bias. See M T Tang,
N S Weiss, J R Daling, and K E Malone, ‘Case-control
differences in the reliability of reporting a history of
induced abortions’, Am. J. Epidemiol., 2000, 151:
1139–43.
52P A Newcomb, B E Storer, M P Longnecker,
R Mittendorf, E R Greenberg, and W C Willett,
‘Pregnancy termination in relation to risk of breast
cancer’, J. Am. med. Assoc., 1996, 275: 283–7,
onp.286;MARookusandFEvanLeeuwen,‘Induced
abortion and risk for breast cancer: reporting (recall)
bias in a Dutch case-control study’, J. Nat. Cancer
Inst., 4 Dec. 1996, 88: 1759–64.
53L Lipworth, K Katsouyanni, A Ekbom,
K B Michels, and D Trichopoulos, ‘Abortion and the
risk of breast cancer: a case-control study in Greece’,
Int. J. Cancer, 1995, 61: 181–4, on p. 184; A Tavani,
C La Vecchia, S Franceshci, E Negri, B D’Avanzo,
and A Decarli, ‘Abortion and breast cancer’,
Int. J. Cancer, 1996, 65: 401–5, on p. 404.
54M D Gammon, J E Bertin, and M B Terry,
‘Abortion and the risk of breast cancer: is there a
believable association?’, J. Am. med. Assoc., 24–31
Jan. 1996, 275: 321–2, on. p. 322.
55See publications list, Joel Brind’s website,
op. cit., note 40 above.
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Patricia Jasencancer link as part of his argument. When testifying at the FDA’s advisory committee
hearing in 1996, he predicted that ‘‘thousands upon thousands’’ of women would get breast
cancer as a result of having used this drug.
56 That year, Brind also published a lengthy
review and meta-analysis of twenty-three studies dealing with induced abortion and cancer
and thus entered into a dialogue with the epidemiological community. In his version of the
history of the abortion-breast cancer debate, he described how a positive association had
first been observed in Japan in 1957, and how, since then, such findings were consistently
ignored or their validity questioned even by those who had conducted the research. He
determinedthat,takentogether,thestudiesprovedthatabortionraised theriskofcancerby
at least 30 per cent. In his view, there was ‘‘overwhelming evidence’’ that recall bias was
not a factor, and he used data from a variety of studies to argue that, while spontaneous
abortion did not lead to higher cancer risk, induced abortion elevated risk irrespective of
when it occurred in a woman’s reproductive life. He concluded that the studies published
thus far, whether prospective or retrospective, produced a very consistent, positive asso-
ciation between induced abortion and breast cancer independent from all other risk factors,
including nulliparity.
57 More studies might be useful, said Brind and his co-authors, but
‘‘there exists the more present need for those in clinical practice to inform their patients
about what is already known’’.
58
The fact that Brind had gained a hearing through a reputable medical journal made him
more difficult to ignore and affected the tenor of the debate in the wider research com-
munity. At least some researchers felt the need to respond directly to his challenge, while
at the same time using this opportunity to confront the wider problem of bias as it affected
their discipline. At the Harvard University School of Public Health, Karin Michels and
Walter Willett conducted their own survey of the medical literature on abortion and
breast cancer and concluded, unlike Brind, that the investigation to date did not permit
a final assessment of the issue.
59 When interviewed for the Harvard University Gazette,
Michels pointed again to the problem of recall bias in retrospective studies, and ques-
tioned Brind’s method of combining a series of reports and attempting to arrive at an
overall estimate, ‘‘instead of trying to understand why the studies differ in their results’’.
60
56W Wright, ‘The deceit behind RU-486: Who’s
really in control?’, Family Voice, Nov.–Dec. 2000,
p. 2, at http://www.cwfa.org/familyvoice/2000-11/
14-19.asp (accessed 5 Jan. 2002).
57J Brind, V M Chinchilli, W B Severs, and
JoanSummy-long,‘Inducedabortionasanindependent
risk factor for breast cancer: a comprehensive review
and meta-analysis’, J. Epidemiol. Community Health,
1996, 50: 481–96. None of the authors was an
epidemiologist. Severs and Summy-Long were
endocrinologists and abortion opponents; Chinchilli
was a statistician who later described how he tried to
temper Brind’s conclusions. See Yeoman, op. cit.,
note 17 above, p. 57.
58Brind, et al., op. cit., note 57 above, p. 495.
There was some evidence that patients were being
advised of the possible risk. See M M Henderson and
A McTiernan, ‘Clinical programs for breast cancer
protection’, in Basil Stoll (ed.), Reducing breast
cancer risk in women, Dordrecht, Kluwer Academic
Publishers, 1995, p. 179; ‘Letters to the Editor’,
regardingLucilleCanty,‘Breastcancerrisk:protective
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Forum, Nov.–Dec. 1997, 24: 1671–2.
59K B Michels and W C Willett, ‘Does induced or
spontaneous abortion affect the risk of breast cancer?’,
Epidemiol., 1996, 7: 521–28, on p. 521. For a similar
study by a team at the American Cancer Society, see
P A Wingo, K Newsome, J S Marks, E E Calle,
S L Parker, ‘The risk of breast cancer following
spontaneous or induced abortion’, Cancer Causes and
Control, 1997, 8: 93–108.
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Breast Cancer and the Politics of Abortion in the United StatesResponding both to Brind and Michels, an editorial in the Journal of the National Cancer
Institute asked how two reviews with the same objective could produce such different
results, and posed the question of whether the problem of bias was a sign that epidemiol-
ogy had ‘‘reached its limit’’. Recall bias was one issue, but another was what they termed
‘‘wish bias’’, or ‘‘the extent to which a reviewer believes a priori that the hypothesis is
true’’. They were critical of Brind’s meta-analysis and his ‘‘blurring of association with
causation’’, and used his work as a case study in how epidemiologists must learn to
recognize when biases are being reproduced in a succession of studies, and why this
occurs. ‘‘Indeed’’, they concluded, ‘‘after this excursion into the issue of abortion, bias,
and breast cancer, it seems our future has as much to do with human behavior as with
human biology’’.
61
In this atmosphere of uncertainty, a major study which was free from the problem of
recall bias was bound to gain attention. In 1997, the New England Journal of Medicine
published the results of research by Mads Melbye and colleagues in Denmark, which used
the Danish national registries of induced abortions and breast cancer cases to study a
cohort of 1.5 million women born between 1935 and 1978. It reported that induced
abortion carried a relative risk of 1.0, indicating that there was no link between abortion
and breast cancer.
62 Criticizing Brind directly, Melbye pointed out that he had relied
almost entirely on case-control studies and had based his results on ‘‘a crude analysis of
published odds ratios and relative risks with no attempt to incorporate the original raw data
into a more sophisticated statistical analysis’’.
63 The accompanying editorial by Patricia
Hartge of the National Cancer Institute also attacked Brind, touted Melbye’s study as
definitive, and added fat to the fire by concluding that ‘‘a woman need not worry about the
risk of breast cancer when facing the difficult decision of whether to terminate a preg-
nancy’’.
64 But flaws in Melbye’s research left that position open to attack. By his own
admission, the fact that pre-1973 abortion information was not included could lead to an
under-estimation of a link with breast cancer among older women.
65 Other researchers
noted, as well, that it was far too early to know what the breast cancer incidence would be
for women in the study who were born as recently as the 1970s—an age group for which
abortion rates would have been comparatively high.
66 Brind and his followers would soon
exploit these limitations to the full, but they were arguably less motivated by a quest for
scientific credibility than by the imperatives of the anti-abortion cause. In Brind’s words,
following the publication of Melbye’s report, his telephone ‘‘was ringing off the hook,
mostly from pro-lifers who had signed onto the ABC link based on my witness and were
now being barraged with tough questions about their new found anti-abortion argument
that went bust’’.
67
61D L Weed and B S Kramer, ‘Induced abortion,
bias, and breast cancer: why epidemiology hasn’t
reacheditslimit’,J.Nat. CancerInst., 4Dec.1996,88:
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62M Melbye, J Wohlfahrt, J H Olsen, M Frisch,
T Westergaard, K Helweg-Larsen, and P K Andersen,
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New Engl. J. Med., 9 Jan. 1997, 336: 81–5.
63Ibid., p. 84.
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epidemiology’, New Engl. J. Med., 9 Jan. 1997,
336: 127–8.
65Melbye, et al., op. cit., note 62 above, p. 84.
66L L Bartholomew and D A Grimes, ‘Focus on
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This final section of the paper will examine more closely how the so-called ‘‘ABC link’’
was incorporated into the strategy taken by anti-abortion activists after the collapse of
direct action in the mid-1990s, a strategy still in use ten years later. Central to their
rhetorical approach is the notion of informed consent—the argument that women have
a right to know about the health risks associated with abortion, and that the link to cancer
has been both irrefutably proved and deliberately concealed by the medical establishment.
Elements of this phase of the campaign have included the founding of organizations, such
as the Breast Cancer Prevention Institute, whose members speak publicly and testify on
this issue whenever possible;extensive useof the internettowarn women against abortion;
the use of pregnancy-counselling centres to spread the ABC message; lobbying efforts
to secure allies in Washington and to pressure the National Cancer Institute to change its
stance on the issue; campaigns for state legislation intended to delay or discourage
abortion—such as ‘‘Women’s Right to Know’’ laws; and the mounting of malpractice
suits against abortion clinics and physicians with the intent of making them uninsurable.
All of these tactics are ostensibly directed towards breaking down a wall of silence
which prevents women from knowing the truth. They also employ a common rhetorical
strategy which gained steadily in importance as majority opinion in the US shifted towards
a greater acceptance of reproductive choice. Instead of the exclusive emphasis on fetal
rights and the portrayal of women who choose abortion as murderers, the newer ‘‘women-
centred’’ strategy presents such women as the uninformed, unwitting victims of a pro-
abortion culture and industry.
68 While the focus on fetal rights appeared to disregard the
needs and rights of women (and lost support as a result), this strategy presents itself as
protective, sympathetic, forgiving,and ready to help the woman suffering psychological or
physical harm resulting from her abortion. As Leslie Cannold observes, activists using this
approach co-opt what they perceive as feminist rhetoric and depict themselves ‘‘as having
an agenda-less desire’’ to defend women against patriarchal pressure and a medical estab-
lishmentdeterminedtoconcealthetruth.Inaddition,throughitsinsistencethatamajorityof
womenwhoabortwillsuffertraumaorillness,itseekstonormalize‘‘acatastrophicviewof
abortion’’.
69
A ‘‘woman-centred’’ approach has been Joel Brind’s strategy from the beginning.
After his meta-analysis proved ineffective in allaying the scepticism still dominant in
themedicalcommunity,hebroadenedhiseffortsbyfoundingtheBreastCancerPrevention
Institute in 1999 in order to publicize, by his own account, ‘‘risk reduction strategies not
widely known to the public and healthcare professionals’’.
70 The BCPI website represents
itself as a clearing house for new information on cancer risk, but its real purpose is to warn
women about the ABC link who might otherwise ‘‘feel helpless and hopeless when it
comes to their risk of developing breast cancer’’.
71 In comparison with other sites focused
on this issue, Brind’s is a model of restraint, although it does appropriate the folded pink
68L Cannold, ‘Understanding and responding to
anti-choice, women-centred strategies’, Reproductive
Health Matters, May 2002, 10: 171–9.
69Ibid., electronic version, pp. 4, 6.
70‘The development of the
Breast Cancer Prevention Institute’,
http://www.bcpinstitute.org/history.htm
(accessed 2 Oct. 2003).
71Breast Cancer Prevention Institute,
‘Breast cancer: risks and prevention’,
http://www.bcpinstitute.org/booklet.htm
(accessed 21 Oct. 2003).
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Breast Cancer and the Politics of Abortion in the United Statesribbon, the familiar symbol of breast cancer activism and fund-raising, to mark each link
on its site navigation bar. The educational functions of the BCPI include public lectures
and presentations at conferences, as well as the production of brochures, audio and
video tapes, and commercials for public broadcast, including a television commercial
called ‘‘I wish I had known’’.
72 A common theme in all of its literature is the conspiracy
of silence.
Closely associated with Brind is Angela Lanfranchi, a co-founder of the Breast Cancer
PreventionInstituteanditsvice-president.Asafemalebreastsurgeon,Lanfranchiemploys
awoman-centredstrategytostrongeffect.Inherportrayalofherowninvolvementwiththe
issue, she recalls how, when she first heard of the abortion-breast cancer link, she thought
it was a ‘‘pro-life fantasy’’. She then began asking her young cancer patients about their
reproductive histories and found that some of them had indeed had abortions. Brind’s
1996 meta-analysis then confirmed for her that the link was real.
73 In a talk delivered on
14 November 2002 at Georgetown University, she related how she watched her mother die
of breast cancer at the same time as she was realizing that cancer patients ‘‘were no longer
post-menopausal grandmothers but young 30-year-old mothers with toddlers. I knew
from my own painful experience what they would face’’. Identifying herself as part of
the Roe v Wade generation and, at times, referring to women’s ‘‘right’’ to end unwanted
pregnancies, Lanfranchi claims to see the heartbreaking toll abortion takes in her practice
‘‘every day’’.
74
The Coalition on Abortion/Breast Cancer has goals similar to the Breast Cancer Pre-
vention Institute, but is more openly devoted to the single cause. It was founded in 1999
by Karen Malec, a former teacher who, like Brind, has spoken widely and testified before
government committees on this issue.
75 Malec describes her coalition as a grassroots
coming-together of cancer survivors and their families (she had been treated for colon
cancer) and women who have had abortions.
76 In fact, the coalition was founded with the
support of Concerned Women for America, a national right-wing Christian organization
which defines itself as anti-gay, anti-choice, anti-feminism and anti-sex education (as well
as anti-Harry Potter) and actively lobbies for legislation recognizing the abortion-breast
cancerlink.
77TheCoalition’sadvisoryboardincludesJoelBrind;formerUSCongressman
and medical doctor Chris Kahlenborn (author of Breast cancer: its link to abortion and
the birth control pill (2000) and an opponent of all forms of artificial contraception);
72Breast Cancer Prevention Institute,
‘Resources for breast cancer prevention’,
http://www.bcinstitute.org/resources.htm
(accessed 21 Oct. 2003).
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1045330466585.html (accessed 22 March 2004).
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http://suewidemark.com/abclinkmdtalk.htm
(accessed 16 Oct. 2003).
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76Coalition on Abortion/Breast Cancer,
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77Catherina Hurlburt, Concerned Women for
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8 Dec. 2000, http://www.cwfa.org/
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CWA&categoryid¼life (accessed 22 March 2004);
People for the American Way, Right Wing Watch,
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general/efault.aspx?oid¼3151 (accessed 10 Jan.
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aid/818/context/over/ (accessed 17 Jan. 2004).
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Patricia JasenJohn Kindley, a lawyer who seeks out and represents women willing to sue abortion
providers for not informing them of the cancer link; Charles Francis, an Australian lawyer
who won the first successful malpractice suit of this kind; and his wife Babette Francis,
who heads an organization allied with Malec’s.
78 The coalition’s pink and blue logo
consists of the words ‘‘Abortion Breast Cancer’’ printed over a large image of the folded
pink ribbon, representing the organization’s intent to co-opt an emotion-laden symbol and
to supplant the breast cancer movement’s influence or authority.
79 The coalition’s rhetoric
is woman-centred, to the point of asserting that ‘‘women have the exclusive right to be
decision makers where their own health care is concerned...we find it paternalistic that
women have been prevented from making informed choices about this women’s health
issue’’.
80
Rescuing potential victims of misinformation is part of these organizations’ mandate,
and pregnancy counselling centres, whose purpose is generally to discourage abortion, can
provide a venue for active intervention. Brind tells the story of how he received a call
from a pregnancy-crisis centre in the Bronx, where the counsellor, having seen the BCPI
website, was seeking help for a client. Thirty-one year old Juanita had been advised by her
physician to have an abortion, which would have been her second, because she had been
diagnosed with breast cancer. Brind referred her to Lanfranchi, who persuaded Juanita to
carry the baby to term, and Brind credited himself with having saved her life. ‘‘For
Juanita’’, he wrote, ‘‘not only did the abortion of her first pregnancy...probably cause
her breast cancer in the first place, but another abortion would likely seal her fate’’.
81 The
core of the problem was that Juanita’s physician did not ‘‘know’’ that ‘‘a woman who is
pregnant when diagnosed with breast cancer...is much more likely to be cured if she has
the baby, instead ofanabortion’’.
82Brind’sonesourceforthis informationwasa Canadian
study published in 1989, based on the records of 154 pregnant breast cancer patients
treated at Toronto’s Princess Margaret Hospital between 1931 and 1985, 21 of whom,
in this 54-year period, had abortions and subsequently died. Its authors advised against
abortion for such patients, but at the same time cautioned that treatment should be minimal
in order to avoid harming the fetus.
83 Not only is the study rife with methodological and
ethical problems, but more credible studies have shown that, in most cases, abortion in
itself neither worsens nor improves a patient’s prognosis. They show that all such cases are
profoundly complicated by intertwining social and medical implications.
84
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Breast Cancer and the Politics of Abortion in the United StatesA very public target of the anti-abortion movement has been the National Cancer
Institute, not only for its dismissal of Daling’s findings and uncritical support of Melbye’s
report, but also for the information supplied on its website, which potentially reaches
millions of women around the world. After Melbye’s study was published, the site’s fact
sheet asserted that ‘‘there is no convincing evidence of a direct relationship between breast
cancer and either induced or spontaneous abortion’’.
85 The NCI came under sustained
attack from Brind and his supporters, including those in Washington and, at a hearing
into ‘The State of Cancer Research’ in July 1998, Congressman Tom Coburn (a leading
advocate of abstinence-only sex education
86) accused the NCI of concealing forty-one
years of research demonstrating the existence of an abortion-breast cancer link. Political
pressure led the agency to modify its web page the following year to say that the evidence
was ‘‘inconsistent’’, but, under the administration of George W Bush, demands mounted
in Congress fora further investigation,leadingto anotherrevision which suggested a much
stronger association between abortion and cancer.
87 Amidst a growing uproar, the NCI
withdrew the fact sheet and scheduled a conference for February 2003, in order to revisit
the issue. Pro-choice advocates attacked the agency for allowing abortion politics to drive
the cancer research agenda, but when the majority of the assembled scientists, among
themDaling,Rosenberg,Russo,andMelbye, reached anapparentconsensusthat‘‘induced
abortion is not associated with an increase in breast cancer risk’’, Brind and his supporters
accused the NCI of a politically-motivated whitewash.
88
Although proponents of the abortion-breast cancer link lobby under the banner of
informed consent, their efforts clearly dovetail with other strategies employed in what
has been called ‘‘the quiet war on abortion’’ during the past ten years.
89 State legislation
requiringmandatorywaitingperiods,parentalconsent,andspecificcounsellingprocedures
has been sought since the 1970s as a means of circumventing the limits imposed by Roe v
Wade, but such efforts intensified during the mid-1990s and quickly became associated
with the issue of a breast cancer link.
90 Within a year of the publication of Daling’s report,
legislation had been passed in two states and proposed in several others, either directing
authorities to investigate the cancer link or taking the form of ‘‘Women’s Right to Know’’
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Patricia Jasenacts requiringthat women be advisedof a possible cancerrisk.
91 The argument forparental
consent laws, similarly, uses the danger of breast cancer to underscore the need for parents
to be in control of their teenage daughters’ health decisions. Such legislation is usually
challenged, but statements made during the highly publicized court cases often enter into
the rhetoric of the wider debate. A classic example of this process involved the suit by
abortion providers against Florida’s Parental Notification Law in 1999, which had already
been twice struck down and revived. The case saw Joel Brind and Lynn Rosenberg as
opposing expert witnesses,
92 and, while the law was eventually overturned in 2003, both
Brind’s and Malec’s organizations seized upon a portion of Rosenberg’s testimony as
evidence that ‘‘even Planned Parenthood’s own expert’’ accepts that abortion posed a
cancer risk for young women.
93 In reality, Rosenberg had merely agreed under cross-
examination that a pregnant 15-year-old who aborts will have a higher life time risk of
breast cancer than the adolescent who carries her baby to term and reaps the benefit of
very early childbearing.
The mid-1990s also saw the emergence of lawsuits which had a similar goal of limiting
access to abortion under the guise of ensuring informed consent.
94 Early in 1995, the
BritishMedicalJournalnotedthegrowingimportanceofmalpracticesuitsintheUSaimed
at forcing abortionists out of business. The author described how an organization called
Life Dynamics assembled evidence of the alleged harm caused to individual women
following abortion, including the danger of breast cancer, while helping to link lawyers
with potential clients. Their long-term goal was to establish the legal understanding that
women could sue, even years later, for any adverse effects of abortion. Even though most
malpractice suits of this kind have not been successful, abortion providers who win their
cases may still be considered an actuarial risk and have difficulty obtaining insurance.
95
American anti-abortionists have drawn encouragement from the recent settlement of an
Australian suit based, in part, on the breast cancer link,
96 and, in 2003, Concerned Women
for America announced the first case won in the US on behalf of the parents of a young
Philadelphia woman. The award included the cost of ‘‘regular medical screening for breast
cancer and future counseling’’.
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91Gammon, et al., op. cit., note 54 above, p. 322.
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Breast Cancer and the Politics of Abortion in the United StatesIn addition to suits involving individual practitioners, clinics have also been targeted for
failingtoinformwomenofthebreastcancerlink.Thefirstandmostwidelypublicizedcase
of this kind began in 1999, and its three and a half year history involved many of the major
players on both sides of the conflict. A false advertising suit was filed against Red River
Women’s Clinic in Fargo, North Dakota, for stating in its information brochure (based on
the National Cancer Institute’s 1996 fact sheet) that medical research did not support
claims that abortion increases breast cancer risk.
98 The suit was filed by Amy Jo Mattson,
variously referred to as a ‘‘sidewalk counselor’’ and an anti-abortion activist serving as
a ‘‘front person for the antis’’ who were using the case as a testing ground.
99 Active sup-
porters included the local pregnancy crisis centre and the Fargo Catholic Diocese, which
had originally prompted the clinic to make the statement in question by placing billboards
along the interstate highway asking: ‘‘‘What increases your risk of breast cancer?’
‘Abortion’’’.
100 Mattson was represented by John Kindley, who was engaged in a similar
case in San Diego. If successful, explained Kindley, such a suit could ‘‘open the abortion
industry up to hundreds of tobacco-like lawsuits...There are millions of women with
potential causes of action out there’’.
101 The clinic was represented by Linda Rosenthal, on
behalf of the Center for Reproductive Law and Policy based in New York City.
102 While
the suit, on the surface, had to do with the nature of informed consent, in the clinic’s view
its covert goals were ‘‘to scare women out of getting abortions and drain clinic resources’’
through legal expenses.
103 The case finally went to trial in March 2002. Lynn Rosenberg
was among the expert witnesses called by the defence, while the plaintiff’s side relied on
the testimony of Joel Brind. Once again, Daling’s 1994 study competed with Melbye’s
1997 report for credibility in the courtroom, and the scientific integrity of the National
Cancer Institute was once more at issue. After a three-day trial, the judge ruled in favour of
the defendant and also declared it reasonable that the clinic rely on the conclusions of
authoritiessuchastheNCI.
104MattsonappealedthedecisiontotheNorthDakotaSupreme
Court, which upheld the original decision. Proponents of the abortion-breast cancer link
were vocal in their disappointment. ‘‘The court’s decision stripped women of their right to
informed consent’’, Malec protested. ‘‘Women will die andchildren will lose their mothers
suit’, Concerned Women for America, 19 Nov. 2003,
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Patricia Jasenbecause the abortion industry is consistently pro-death’’.
105 There was some gratification,
however,intheattentionthecaseandthewiderissuehadreceived.TheLosAngelesTimes,
reporting on the trial, had described the furore over the cancer link as ‘‘the ferocious new
front line in the abortion wars’’.
106
In the early years of the twenty-first century, however, the weight of medical evidence,
some of which has emerged from countries where abortion is extremely common, con-
tinues to shift away from an association between abortion and breast cancer.
107 Very
recently, members of the Collaborative Group on Hormonal Factors in Breast Cancer,
based at Radcliffe Infirmary in Oxford, published the results of a massive re-analysis of
available data, which failed to confirm a link with abortion.
108 Both the American College
of Obstetricians and Gynecologists and its counterpart in the United Kingdom have
respondedtotheongoingcampaigntolinkabortionandbreastcancerbydeclaringpublicly
that, although the search for better methodological approaches to the question continues,
there is no evidence at present to justify further anxiety over the issue.
109 Even though
proponents of the abortion-breast cancer link have lost credibility in the international
research community, their campaign continues to gain willing converts, influence abortion
legislation in a number of US states, and raise painful questions for women facing breast
cancer or difficult reproductive choices. ‘‘Did I deserve my disease?’’ asked one American
journalist,afteradoublemastectomyattheageofthirty-eight.Anxioustolearnmoreabout
abortion and breast cancer, she spoke to individuals on both sides of the controversy, and,
not surprisingly, received unequivocal yet completely opposing responses from both Brind
and Rosenberg. From her perspective, there is no certainty or clarity, just a stronger
awareness of the basic truth, in her words, that ‘‘science and ideology’’ are ‘‘hopelessly
intertwined’’.
110
Conclusion
The abortion-breast cancer debate provides a particularly vivid illustration of how a
variety of narratives may become intertwined in the complex history of medical risk.
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Breast Cancer and the Politics of Abortion in the United StatesArising, at first, out of the post-war study of reproductive factors and breast cancer, the
question of how abortion might affect cancer risk became more open to study after the
procedure waslegalizedinmany countries inthe1960sand1970s.IntheUS,the aftermath
of Roe v Wade coincided with the rise of evangelical Christianity as a major social and
political force, and epidemiological research soon became a weapon in the wider struggle
over abortion. As the conflict intensified and anti-abortionists replaced violent strategies
with a more acceptable ‘‘woman-centred’’ approach, they adopted the ‘‘ABC link’’ as a
means of fighting abortion in Congress, state legislatures and courts of law. Epidemio-
logists were inevitably drawn into the war of words and found themselves losing control
over how their results were interpreted or put to use. As a by-product of this process, they
were also provoked into a closer examination of how various kinds of bias operate within
their own discipline, and why apparently similar studies may produce dramatically dif-
ferent results. Ironically, however, it is not only the methodologies underlying contra-
dictory conclusions which need closer examination, but also the processes which allow
studies to keep replicating results which are later discredited. An historical approach has
much to offer in this regard. For example, an analysis of how a series of researchers
interprets the existing literature concerning a potential risk factor provides insights into
how quickly the specific nature of earlier studies slips from view, and how tentative
conclusions may become fossilized or reified as citations accumulate. As the literature
grows,themethods andresultsofstudiesareinfluencedbythe developingepidemiological
narrative, at the same time as they are also affected by the wider historical contexts in
which the researchquestions have come to light, been deemed worthyof investigation, and
been subsequently shaped or altered by social pressures. The abortion-breast cancer debate
hasbeenparticularlycomplexbecauseofthemedical,social,andpoliticalsignificanceofa
dread disease seemingly out of control, and because of the emotional intensity surrounding
the entire history of the conflict over abortion in the United States. The inseparability of
science from social context confronts all those who attempt to find their way through the
maze of conflicting evidence, motives, aims and strategies that have characterized this
debate,whethertheyareepidemiologists,historians,clinicians,orthewomenwhosehealth
is at the heart of the question.
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